

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-amino acid import (GO:0043092) | 6.31757135 |
| 2 | alanine transport (GO:0032328) | 6.26596645 |
| 3 | amino acid import (GO:0043090) | 6.15453623 |
| 4 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.88547046 |
| 5 | C4-dicarboxylate transport (GO:0015740) | 5.42197806 |
| 6 | cellular potassium ion homeostasis (GO:0030007) | 5.21304319 |
| 7 | vitamin A metabolic process (GO:0006776) | 5.16100238 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 5.02141908 |
| 9 | chondroitin sulfate catabolic process (GO:0030207) | 4.95429657 |
| 10 | gamma-aminobutyric acid transport (GO:0015812) | 4.88515922 |
| 11 | negative regulation of astrocyte differentiation (GO:0048712) | 4.86641755 |
| 12 | sodium ion export (GO:0071436) | 4.85063322 |
| 13 | L-serine transport (GO:0015825) | 4.73126747 |
| 14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.72877529 |
| 15 | neuronal ion channel clustering (GO:0045161) | 4.70382597 |
| 16 | cell communication by electrical coupling (GO:0010644) | 4.60371032 |
| 17 | axon ensheathment in central nervous system (GO:0032291) | 4.45178038 |
| 18 | central nervous system myelination (GO:0022010) | 4.45178038 |
| 19 | low-density lipoprotein particle remodeling (GO:0034374) | 4.42325452 |
| 20 | regulation of synaptic vesicle transport (GO:1902803) | 4.22043083 |
| 21 | potassium ion import (GO:0010107) | 4.20336931 |
| 22 | presynaptic membrane organization (GO:0097090) | 4.17418719 |
| 23 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.17417115 |
| 24 | postsynaptic membrane organization (GO:0001941) | 4.13143185 |
| 25 | presynaptic membrane assembly (GO:0097105) | 4.12961914 |
| 26 | locomotory exploration behavior (GO:0035641) | 4.10390488 |
| 27 | serine transport (GO:0032329) | 4.07424940 |
| 28 | neurotransmitter uptake (GO:0001504) | 3.97936974 |
| 29 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.97137875 |
| 30 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.94838055 |
| 31 | response to auditory stimulus (GO:0010996) | 3.94411163 |
| 32 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.89890194 |
| 33 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.88760145 |
| 34 | microglial cell activation (GO:0001774) | 3.85503189 |
| 35 | dermatan sulfate metabolic process (GO:0030205) | 3.84455317 |
| 36 | cellular response to electrical stimulus (GO:0071257) | 3.79739882 |
| 37 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.78118677 |
| 38 | proline transport (GO:0015824) | 3.77789856 |
| 39 | cellular sodium ion homeostasis (GO:0006883) | 3.77209494 |
| 40 | adenine nucleotide transport (GO:0051503) | 3.71987605 |
| 41 | acidic amino acid transport (GO:0015800) | 3.71924998 |
| 42 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.71243231 |
| 43 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.69674630 |
| 44 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.68940530 |
| 45 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.64246991 |
| 46 | neurotransmitter transport (GO:0006836) | 3.62397801 |
| 47 | adenosine receptor signaling pathway (GO:0001973) | 3.61362992 |
| 48 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.58560844 |
| 49 | ovulation cycle (GO:0042698) | 3.58332309 |
| 50 | one-carbon compound transport (GO:0019755) | 3.56703491 |
| 51 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.54814191 |
| 52 | regulation of beta-amyloid formation (GO:1902003) | 3.46054898 |
| 53 | auditory behavior (GO:0031223) | 3.45165637 |
| 54 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.43470694 |
| 55 | potassium ion homeostasis (GO:0055075) | 3.43094342 |
| 56 | glutamate receptor signaling pathway (GO:0007215) | 3.42276679 |
| 57 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.40224160 |
| 58 | positive regulation of dendritic spine development (GO:0060999) | 3.38339571 |
| 59 | regulation of astrocyte differentiation (GO:0048710) | 3.35373023 |
| 60 | cellular response to cholesterol (GO:0071397) | 3.33381272 |
| 61 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.32158707 |
| 62 | regulation of neurotransmitter levels (GO:0001505) | 3.32017215 |
| 63 | negative regulation of sodium ion transport (GO:0010766) | 3.31034758 |
| 64 | long-term synaptic potentiation (GO:0060291) | 3.30971525 |
| 65 | neuronal action potential propagation (GO:0019227) | 3.28204570 |
| 66 | neuromuscular process controlling balance (GO:0050885) | 3.27925135 |
| 67 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.27530340 |
| 68 | myelination (GO:0042552) | 3.26539646 |
| 69 | regulation of synaptic plasticity (GO:0048167) | 3.25071526 |
| 70 | hyperosmotic salinity response (GO:0042538) | 3.21921500 |
| 71 | regulation of ARF protein signal transduction (GO:0032012) | 3.21890107 |
| 72 | atrial cardiac muscle cell action potential (GO:0086014) | 3.20274587 |
| 73 | axon ensheathment (GO:0008366) | 3.19587357 |
| 74 | ensheathment of neurons (GO:0007272) | 3.19587357 |
| 75 | purine nucleotide transport (GO:0015865) | 3.19579880 |
| 76 | positive regulation of synapse maturation (GO:0090129) | 3.18698874 |
| 77 | myelin maintenance (GO:0043217) | 3.18462550 |
| 78 | regulation of neurotransmitter secretion (GO:0046928) | 3.17823416 |
| 79 | phosphorelay signal transduction system (GO:0000160) | 3.17182261 |
| 80 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.16364600 |
| 81 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.15268414 |
| 82 | positive regulation of membrane potential (GO:0045838) | 3.14239069 |
| 83 | L-glutamate transport (GO:0015813) | 3.13949180 |
| 84 | synaptic transmission, glutamatergic (GO:0035249) | 3.10916059 |
| 85 | regulation of synapse structural plasticity (GO:0051823) | 3.10823185 |
| 86 | astrocyte development (GO:0014002) | 3.10235898 |
| 87 | protein localization to synapse (GO:0035418) | 3.09902473 |
| 88 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.09709298 |
| 89 | regulation of phospholipid biosynthetic process (GO:0071071) | 3.09021083 |
| 90 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.08545875 |
| 91 | regulation of neurotransmitter transport (GO:0051588) | 3.08351073 |
| 92 | synaptic vesicle endocytosis (GO:0048488) | 3.06729164 |
| 93 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.06178883 |
| 94 | relaxation of smooth muscle (GO:0044557) | 3.02414002 |
| 95 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.01587379 |
| 96 | response to histamine (GO:0034776) | 3.01563429 |
| 97 | negative regulation of smoothened signaling pathway (GO:0045879) | 2.99494470 |
| 98 | negative regulation of norepinephrine secretion (GO:0010700) | 2.99121487 |
| 99 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.99083578 |
| 100 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.98050403 |
| 101 | regulation of female receptivity (GO:0045924) | 2.97208177 |
| 102 | regulation of dendritic spine development (GO:0060998) | 2.95853588 |
| 103 | purine ribonucleotide transport (GO:0015868) | 2.95275545 |
| 104 | kidney morphogenesis (GO:0060993) | 2.94150606 |
| 105 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.93843688 |
| 106 | transmission of nerve impulse (GO:0019226) | 2.93828448 |
| 107 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.92588038 |
| 108 | protein-chromophore linkage (GO:0018298) | 2.92444962 |
| 109 | daunorubicin metabolic process (GO:0044597) | 2.89017082 |
| 110 | polyketide metabolic process (GO:0030638) | 2.89017082 |
| 111 | doxorubicin metabolic process (GO:0044598) | 2.89017082 |
| 112 | glial cell proliferation (GO:0014009) | 2.88559621 |
| 113 | aggressive behavior (GO:0002118) | 2.88377432 |
| 114 | glutamate secretion (GO:0014047) | 2.88272091 |
| 115 | positive regulation of potassium ion transport (GO:0043268) | 2.87207399 |
| 116 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.86580781 |
| 117 | neuron cell-cell adhesion (GO:0007158) | 2.84646035 |
| 118 | negative regulation of inclusion body assembly (GO:0090084) | 2.84314244 |
| 119 | negative regulation of glial cell differentiation (GO:0045686) | 2.81637147 |
| 120 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.81523519 |
| 121 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.81236052 |
| 122 | cellular response to sterol (GO:0036315) | 2.79652975 |
| 123 | membrane assembly (GO:0071709) | 2.79566881 |
| 124 | adult walking behavior (GO:0007628) | 2.79278749 |
| 125 | vocalization behavior (GO:0071625) | 2.79233185 |
| 126 | regulation of cell communication by electrical coupling (GO:0010649) | 2.78867424 |
| 127 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.78379597 |
| 128 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.77767085 |
| 129 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.77719761 |
| 130 | nucleoside diphosphate catabolic process (GO:0009134) | 2.77453920 |
| 131 | mechanosensory behavior (GO:0007638) | 2.76357463 |
| 132 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.76355519 |
| 133 | regulation of membrane repolarization (GO:0060306) | 2.74138625 |
| 134 | long-term memory (GO:0007616) | 2.73629852 |
| 135 | L-amino acid transport (GO:0015807) | 2.72814932 |
| 136 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.71010363 |
| 137 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.68917899 |
| 138 | neurotransmitter secretion (GO:0007269) | 2.68863670 |
| 139 | cerebellar granule cell differentiation (GO:0021707) | 2.68416769 |
| 140 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.68350420 |
| 141 | neuroblast proliferation (GO:0007405) | 2.67652479 |
| 142 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.61526455 |
| 143 | synaptic vesicle maturation (GO:0016188) | 2.61372363 |
| 144 | regulation of norepinephrine secretion (GO:0014061) | 2.61169194 |
| 145 | lens fiber cell development (GO:0070307) | 2.61089675 |
| 146 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.59963242 |
| 147 | exploration behavior (GO:0035640) | 2.59524474 |
| 148 | regulation of glomerular filtration (GO:0003093) | 2.58236314 |
| 149 | neuron-neuron synaptic transmission (GO:0007270) | 2.57674308 |
| 150 | layer formation in cerebral cortex (GO:0021819) | 2.57626515 |
| 151 | oligodendrocyte differentiation (GO:0048709) | 2.55308406 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.99999022 |
| 2 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.05687581 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.90566333 |
| 4 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.78618659 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.73984321 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.61396584 |
| 7 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.57526567 |
| 8 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.51658373 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.51006327 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.51006327 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.45518368 |
| 12 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.40274780 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.38387359 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.38334720 |
| 15 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.36272596 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.28687709 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.16503656 |
| 18 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.12362289 |
| 19 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.06072675 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.98220178 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.95743746 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.92397732 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.91517802 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.85112184 |
| 25 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.76369646 |
| 26 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.72294531 |
| 27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.61490097 |
| 28 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.60579961 |
| 29 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.55711421 |
| 30 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.52807468 |
| 31 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.50468087 |
| 32 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.49475843 |
| 33 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.48963968 |
| 34 | TP53_16413492_ChIP-PET_HCT116_Human | 1.47340057 |
| 35 | RXR_22108803_ChIP-Seq_LS180_Human | 1.46577968 |
| 36 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.46432179 |
| 37 | P300_19829295_ChIP-Seq_ESCs_Human | 1.46313689 |
| 38 | AR_25329375_ChIP-Seq_VCAP_Human | 1.42515655 |
| 39 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.42245012 |
| 40 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.39703642 |
| 41 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.39029625 |
| 42 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.38663485 |
| 43 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.38026774 |
| 44 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.37779910 |
| 45 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.34949047 |
| 46 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.34748530 |
| 47 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.34707971 |
| 48 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34075430 |
| 49 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.32924979 |
| 50 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.32524385 |
| 51 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.32013206 |
| 52 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.30190716 |
| 53 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.29992278 |
| 54 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.28874914 |
| 55 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.25309477 |
| 56 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.22875731 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22359202 |
| 58 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.21627904 |
| 59 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.21319575 |
| 60 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.20044096 |
| 61 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.19774523 |
| 62 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18962931 |
| 63 | AR_19668381_ChIP-Seq_PC3_Human | 1.17617562 |
| 64 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.17037643 |
| 65 | STAT3_23295773_ChIP-Seq_U87_Human | 1.15889587 |
| 66 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11071328 |
| 67 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.10625415 |
| 68 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.08613341 |
| 69 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.08440982 |
| 70 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.08378805 |
| 71 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07765769 |
| 72 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.07652172 |
| 73 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07556960 |
| 74 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07539922 |
| 75 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.05489674 |
| 76 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04244995 |
| 77 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.03898801 |
| 78 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.02142229 |
| 79 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01414564 |
| 80 | KDM2B_26808549_Chip-Seq_K562_Human | 1.00308549 |
| 81 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00297676 |
| 82 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99730396 |
| 83 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.98788842 |
| 84 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98758439 |
| 85 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98363402 |
| 86 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.98286119 |
| 87 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.97499593 |
| 88 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.97023081 |
| 89 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95663428 |
| 90 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.95107969 |
| 91 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95024792 |
| 92 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.94804002 |
| 93 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.94487094 |
| 94 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94062146 |
| 95 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.93797414 |
| 96 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.92963681 |
| 97 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92771049 |
| 98 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.92020001 |
| 99 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.91534985 |
| 100 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91534985 |
| 101 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.90868294 |
| 102 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.90439496 |
| 103 | TCF4_23295773_ChIP-Seq_U87_Human | 0.89954101 |
| 104 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.88754862 |
| 105 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88327703 |
| 106 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.87881518 |
| 107 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.87571011 |
| 108 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.86540669 |
| 109 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.85901447 |
| 110 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.85292013 |
| 111 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.85112254 |
| 112 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.84964394 |
| 113 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.84485184 |
| 114 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.84471995 |
| 115 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.83609926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003011_delayed_dark_adaptation | 5.98096629 |
| 2 | MP0003690_abnormal_glial_cell | 4.20184232 |
| 3 | MP0004885_abnormal_endolymph | 4.01650687 |
| 4 | MP0003878_abnormal_ear_physiology | 3.79849315 |
| 5 | MP0005377_hearing/vestibular/ear_phenot | 3.79849315 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 3.56476873 |
| 7 | MP0009384_cardiac_valve_regurgitation | 3.42939307 |
| 8 | MP0005423_abnormal_somatic_nervous | 3.15853289 |
| 9 | MP0004270_analgesia | 2.93938176 |
| 10 | MP0009780_abnormal_chondrocyte_physiolo | 2.80420916 |
| 11 | MP0001486_abnormal_startle_reflex | 2.77281464 |
| 12 | MP0003635_abnormal_synaptic_transmissio | 2.58804336 |
| 13 | MP0005646_abnormal_pituitary_gland | 2.54356268 |
| 14 | MP0004858_abnormal_nervous_system | 2.49991417 |
| 15 | MP0001502_abnormal_circadian_rhythm | 2.49566389 |
| 16 | MP0003329_amyloid_beta_deposits | 2.45727630 |
| 17 | MP0009046_muscle_twitch | 2.37958459 |
| 18 | MP0009745_abnormal_behavioral_response | 2.30000239 |
| 19 | MP0002254_reproductive_system_inflammat | 2.26287756 |
| 20 | MP0000566_synostosis | 2.26112240 |
| 21 | MP0002064_seizures | 2.23161865 |
| 22 | MP0002572_abnormal_emotion/affect_behav | 2.22601821 |
| 23 | MP0002063_abnormal_learning/memory/cond | 2.09117698 |
| 24 | MP0001440_abnormal_grooming_behavior | 2.08944904 |
| 25 | MP0003879_abnormal_hair_cell | 2.06553145 |
| 26 | MP0001485_abnormal_pinna_reflex | 2.05833523 |
| 27 | MP0003880_abnormal_central_pattern | 2.02197083 |
| 28 | MP0003136_yellow_coat_color | 1.88532083 |
| 29 | MP0001501_abnormal_sleep_pattern | 1.88458314 |
| 30 | MP0003075_altered_response_to | 1.82533305 |
| 31 | MP0003634_abnormal_glial_cell | 1.77319818 |
| 32 | MP0003633_abnormal_nervous_system | 1.77030482 |
| 33 | MP0002557_abnormal_social/conspecific_i | 1.67316362 |
| 34 | MP0004019_abnormal_vitamin_homeostasis | 1.66888698 |
| 35 | MP0003172_abnormal_lysosome_physiology | 1.66076513 |
| 36 | MP0002734_abnormal_mechanical_nocicepti | 1.63167712 |
| 37 | MP0001968_abnormal_touch/_nociception | 1.61614738 |
| 38 | MP0008569_lethality_at_weaning | 1.58073831 |
| 39 | MP0002272_abnormal_nervous_system | 1.55265114 |
| 40 | MP0006276_abnormal_autonomic_nervous | 1.54073683 |
| 41 | MP0003279_aneurysm | 1.49469170 |
| 42 | MP0002067_abnormal_sensory_capabilities | 1.46420168 |
| 43 | MP0002736_abnormal_nociception_after | 1.44290447 |
| 44 | MP0000569_abnormal_digit_pigmentation | 1.41424303 |
| 45 | MP0003137_abnormal_impulse_conducting | 1.40588900 |
| 46 | MP0001986_abnormal_taste_sensitivity | 1.36861793 |
| 47 | MP0003631_nervous_system_phenotype | 1.36735610 |
| 48 | MP0004811_abnormal_neuron_physiology | 1.36589952 |
| 49 | MP0005058_abnormal_lysosome_morphology | 1.33969270 |
| 50 | MP0001299_abnormal_eye_distance/ | 1.31984593 |
| 51 | MP0002733_abnormal_thermal_nociception | 1.30591112 |
| 52 | MP0000778_abnormal_nervous_system | 1.29802563 |
| 53 | MP0005670_abnormal_white_adipose | 1.29476433 |
| 54 | MP0000604_amyloidosis | 1.28527766 |
| 55 | MP0002638_abnormal_pupillary_reflex | 1.27810227 |
| 56 | MP0005171_absent_coat_pigmentation | 1.27685562 |
| 57 | MP0004215_abnormal_myocardial_fiber | 1.23231115 |
| 58 | MP0001963_abnormal_hearing_physiology | 1.19973602 |
| 59 | MP0004924_abnormal_behavior | 1.17530581 |
| 60 | MP0005386_behavior/neurological_phenoty | 1.17530581 |
| 61 | MP0001905_abnormal_dopamine_level | 1.13358373 |
| 62 | MP0005551_abnormal_eye_electrophysiolog | 1.09980547 |
| 63 | MP0001984_abnormal_olfaction | 1.09448064 |
| 64 | MP0001970_abnormal_pain_threshold | 1.07101216 |
| 65 | MP0004145_abnormal_muscle_electrophysio | 1.05572485 |
| 66 | MP0001346_abnormal_lacrimal_gland | 1.04883976 |
| 67 | MP0000026_abnormal_inner_ear | 1.04283363 |
| 68 | MP0004142_abnormal_muscle_tone | 1.02454893 |
| 69 | MP0005167_abnormal_blood-brain_barrier | 1.02448232 |
| 70 | MP0002882_abnormal_neuron_morphology | 1.00641955 |
| 71 | MP0002229_neurodegeneration | 1.00355445 |
| 72 | MP0002089_abnormal_postnatal_growth/wei | 0.99656618 |
| 73 | MP0002066_abnormal_motor_capabilities/c | 0.99247412 |
| 74 | MP0005332_abnormal_amino_acid | 0.98204758 |
| 75 | MP0003632_abnormal_nervous_system | 0.95578819 |
| 76 | MP0000920_abnormal_myelination | 0.95115788 |
| 77 | MP0005595_abnormal_vascular_smooth | 0.94129243 |
| 78 | MP0002090_abnormal_vision | 0.90130311 |
| 79 | MP0004742_abnormal_vestibular_system | 0.89994425 |
| 80 | MP0006292_abnormal_olfactory_placode | 0.89912104 |
| 81 | MP0005645_abnormal_hypothalamus_physiol | 0.89269740 |
| 82 | MP0000955_abnormal_spinal_cord | 0.88429458 |
| 83 | MP0001853_heart_inflammation | 0.88215345 |
| 84 | MP0005253_abnormal_eye_physiology | 0.86478737 |
| 85 | MP0008874_decreased_physiological_sensi | 0.83864064 |
| 86 | MP0002152_abnormal_brain_morphology | 0.82673514 |
| 87 | MP0005647_abnormal_sex_gland | 0.81896400 |
| 88 | MP0004043_abnormal_pH_regulation | 0.80044033 |
| 89 | MP0002184_abnormal_innervation | 0.78111262 |
| 90 | MP0001324_abnormal_eye_pigmentation | 0.77257455 |
| 91 | MP0003787_abnormal_imprinting | 0.73855445 |
| 92 | MP0002909_abnormal_adrenal_gland | 0.73227130 |
| 93 | MP0004883_abnormal_blood_vessel | 0.73105313 |
| 94 | MP0001958_emphysema | 0.72861053 |
| 95 | MP0005535_abnormal_body_temperature | 0.71828074 |
| 96 | MP0005195_abnormal_posterior_eye | 0.71637668 |
| 97 | MP0004130_abnormal_muscle_cell | 0.70877675 |
| 98 | MP0000049_abnormal_middle_ear | 0.68665982 |
| 99 | MP0002735_abnormal_chemical_nociception | 0.67453829 |
| 100 | MP0005166_decreased_susceptibility_to | 0.66899175 |
| 101 | MP0005165_increased_susceptibility_to | 0.65436007 |
| 102 | MP0001177_atelectasis | 0.65055475 |
| 103 | MP0005391_vision/eye_phenotype | 0.64880828 |
| 104 | MP0000428_abnormal_craniofacial_morphol | 0.64431081 |
| 105 | MP0004085_abnormal_heartbeat | 0.64381781 |
| 106 | MP0003938_abnormal_ear_development | 0.63401912 |
| 107 | MP0008872_abnormal_physiological_respon | 0.63249846 |
| 108 | MP0005623_abnormal_meninges_morphology | 0.62961890 |
| 109 | MP0009840_abnormal_foam_cell | 0.62023804 |
| 110 | MP0000631_abnormal_neuroendocrine_gland | 0.61858810 |
| 111 | MP0000647_abnormal_sebaceous_gland | 0.61376264 |
| 112 | MP0001529_abnormal_vocalization | 0.61240297 |
| 113 | MP0002752_abnormal_somatic_nervous | 0.60675679 |
| 114 | MP0002822_catalepsy | 0.58839147 |
| 115 | MP0002133_abnormal_respiratory_system | 0.49972142 |
| 116 | MP0005388_respiratory_system_phenotype | 0.49972142 |
| 117 | MP0003123_paternal_imprinting | 0.48446971 |
| 118 | MP0002069_abnormal_eating/drinking_beha | 0.45622967 |
| 119 | MP0003183_abnormal_peptide_metabolism | 0.45124351 |
| 120 | MP0003122_maternal_imprinting | 0.42555494 |
| 121 | MP0005174_abnormal_tail_pigmentation | 0.41498840 |
| 122 | MP0000462_abnormal_digestive_system | 0.41253082 |
| 123 | MP0010386_abnormal_urinary_bladder | 0.40771399 |
| 124 | MP0001943_abnormal_respiration | 0.39772075 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplasia involving bones of the upper limbs (HP:0009823) | 6.69031981 |
| 2 | Aplasia of the phalanges of the hand (HP:0009802) | 6.69031981 |
| 3 | Aplasia involving bones of the extremities (HP:0009825) | 6.69031981 |
| 4 | Abnormality of secondary sexual hair (HP:0009888) | 5.68732506 |
| 5 | Abnormality of the axillary hair (HP:0100134) | 5.68732506 |
| 6 | Onycholysis (HP:0001806) | 4.96887534 |
| 7 | Megalencephaly (HP:0001355) | 4.75239085 |
| 8 | Peripheral hypomyelination (HP:0007182) | 4.64275624 |
| 9 | Diplopia (HP:0000651) | 4.55547819 |
| 10 | Abnormality of binocular vision (HP:0011514) | 4.55547819 |
| 11 | Hemiparesis (HP:0001269) | 4.49896802 |
| 12 | Scanning speech (HP:0002168) | 4.30745882 |
| 13 | Choroideremia (HP:0001139) | 4.18267622 |
| 14 | Neurofibrillary tangles (HP:0002185) | 4.11078371 |
| 15 | Abnormality of nail color (HP:0100643) | 3.99926176 |
| 16 | Ankle clonus (HP:0011448) | 3.98883657 |
| 17 | Febrile seizures (HP:0002373) | 3.91411798 |
| 18 | Focal motor seizures (HP:0011153) | 3.85490841 |
| 19 | Hemiplegia (HP:0002301) | 3.68589789 |
| 20 | J-shaped sella turcica (HP:0002680) | 3.63904628 |
| 21 | Atonic seizures (HP:0010819) | 3.57589585 |
| 22 | Hypoplastic left heart (HP:0004383) | 3.53567495 |
| 23 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.51339229 |
| 24 | Congenital stationary night blindness (HP:0007642) | 3.40119347 |
| 25 | Spastic gait (HP:0002064) | 3.37973712 |
| 26 | Truncal ataxia (HP:0002078) | 3.36607705 |
| 27 | Scotoma (HP:0000575) | 3.16453113 |
| 28 | Epileptic encephalopathy (HP:0200134) | 3.05220021 |
| 29 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.04490000 |
| 30 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.04490000 |
| 31 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.03355321 |
| 32 | Increased circulating renin level (HP:0000848) | 3.02112250 |
| 33 | Cerebral inclusion bodies (HP:0100314) | 3.01499454 |
| 34 | Intention tremor (HP:0002080) | 2.99912195 |
| 35 | Dysmetria (HP:0001310) | 2.94819224 |
| 36 | Mixed hearing impairment (HP:0000410) | 2.94131463 |
| 37 | Broad face (HP:0000283) | 2.91512409 |
| 38 | Ulnar claw (HP:0001178) | 2.90436162 |
| 39 | Alacrima (HP:0000522) | 2.88455090 |
| 40 | Supranuclear gaze palsy (HP:0000605) | 2.87066603 |
| 41 | Decreased central vision (HP:0007663) | 2.86320487 |
| 42 | Abnormality of the corticospinal tract (HP:0002492) | 2.85514509 |
| 43 | Cranial hyperostosis (HP:0004437) | 2.83516079 |
| 44 | Obstructive sleep apnea (HP:0002870) | 2.82853562 |
| 45 | Absent hair (HP:0002298) | 2.81262995 |
| 46 | Termporal pattern (HP:0011008) | 2.76626567 |
| 47 | Insidious onset (HP:0003587) | 2.76626567 |
| 48 | Broad alveolar ridges (HP:0000187) | 2.71723331 |
| 49 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.71128299 |
| 50 | Lower limb muscle weakness (HP:0007340) | 2.71048994 |
| 51 | Abnormality of the dental pulp (HP:0006479) | 2.68598047 |
| 52 | Hypoplastic heart (HP:0001961) | 2.67065122 |
| 53 | Abnormality of the fovea (HP:0000493) | 2.66647629 |
| 54 | Narrow nasal bridge (HP:0000446) | 2.66579245 |
| 55 | Myokymia (HP:0002411) | 2.66460663 |
| 56 | Bundle branch block (HP:0011710) | 2.64018099 |
| 57 | Mutism (HP:0002300) | 2.63293697 |
| 58 | Synostosis involving the elbow (HP:0003938) | 2.58907610 |
| 59 | Humeroradial synostosis (HP:0003041) | 2.58907610 |
| 60 | Torticollis (HP:0000473) | 2.57396765 |
| 61 | Pseudobulbar signs (HP:0002200) | 2.57028794 |
| 62 | Urinary urgency (HP:0000012) | 2.56880258 |
| 63 | Confusion (HP:0001289) | 2.56815333 |
| 64 | Neuronal loss in central nervous system (HP:0002529) | 2.56540238 |
| 65 | Dialeptic seizures (HP:0011146) | 2.55323065 |
| 66 | Absence seizures (HP:0002121) | 2.52453953 |
| 67 | Attenuation of retinal blood vessels (HP:0007843) | 2.49147854 |
| 68 | Abnormality of hair growth rate (HP:0011363) | 2.48674454 |
| 69 | Slow-growing hair (HP:0002217) | 2.48674454 |
| 70 | Biconcave vertebral bodies (HP:0004586) | 2.48595130 |
| 71 | Back pain (HP:0003418) | 2.46787032 |
| 72 | Craniofacial hyperostosis (HP:0004493) | 2.44943466 |
| 73 | Papilledema (HP:0001085) | 2.42982489 |
| 74 | Action tremor (HP:0002345) | 2.41955693 |
| 75 | Brittle hair (HP:0002299) | 2.40507052 |
| 76 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.40361099 |
| 77 | Focal seizures (HP:0007359) | 2.39514691 |
| 78 | Tetraplegia (HP:0002445) | 2.38068984 |
| 79 | Deformed sella turcica (HP:0002681) | 2.36642497 |
| 80 | Short hallux (HP:0010109) | 2.36287908 |
| 81 | Visual hallucinations (HP:0002367) | 2.36064119 |
| 82 | Postural tremor (HP:0002174) | 2.35796818 |
| 83 | Dysostosis multiplex (HP:0000943) | 2.34903619 |
| 84 | Long nose (HP:0003189) | 2.34650920 |
| 85 | Abnormality of the dental root (HP:0006486) | 2.34647309 |
| 86 | Taurodontia (HP:0000679) | 2.34647309 |
| 87 | Abnormality of permanent molar morphology (HP:0011071) | 2.34647309 |
| 88 | Decreased lacrimation (HP:0000633) | 2.33563906 |
| 89 | Fibular aplasia (HP:0002990) | 2.33291491 |
| 90 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.31992813 |
| 91 | Macular degeneration (HP:0000608) | 2.29613145 |
| 92 | Clumsiness (HP:0002312) | 2.28245793 |
| 93 | Blepharitis (HP:0000498) | 2.28072668 |
| 94 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.27783372 |
| 95 | Facial shape deformation (HP:0011334) | 2.27266000 |
| 96 | Potter facies (HP:0002009) | 2.27266000 |
| 97 | Central scotoma (HP:0000603) | 2.24857667 |
| 98 | Progressive cerebellar ataxia (HP:0002073) | 2.24332969 |
| 99 | Generalized tonic-clonic seizures (HP:0002069) | 2.24235170 |
| 100 | Postural instability (HP:0002172) | 2.23678398 |
| 101 | Increased CSF protein (HP:0002922) | 2.23656050 |
| 102 | Abnormality of molar (HP:0011077) | 2.22670182 |
| 103 | Abnormality of molar morphology (HP:0011070) | 2.22670182 |
| 104 | Decreased motor nerve conduction velocity (HP:0003431) | 2.21248661 |
| 105 | Clonus (HP:0002169) | 2.17756092 |
| 106 | Foot dorsiflexor weakness (HP:0009027) | 2.17179837 |
| 107 | Short middle phalanx of the 5th finger (HP:0004220) | 2.17173022 |
| 108 | Bradykinesia (HP:0002067) | 2.16522009 |
| 109 | Upper limb muscle weakness (HP:0003484) | 2.15641914 |
| 110 | Tetraparesis (HP:0002273) | 2.15538865 |
| 111 | Progressive neurologic deterioration (HP:0002344) | 2.15110885 |
| 112 | Multifactorial inheritance (HP:0001426) | 2.14365267 |
| 113 | Epileptiform EEG discharges (HP:0011182) | 2.13963325 |
| 114 | Poor eye contact (HP:0000817) | 2.13878220 |
| 115 | Apathy (HP:0000741) | 2.11826451 |
| 116 | Annular pancreas (HP:0001734) | 2.11539850 |
| 117 | Hyperventilation (HP:0002883) | 2.10385996 |
| 118 | Rigidity (HP:0002063) | 2.10325778 |
| 119 | Status epilepticus (HP:0002133) | 2.10308877 |
| 120 | Delusions (HP:0000746) | 2.10103750 |
| 121 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.09799039 |
| 122 | Split foot (HP:0001839) | 2.09725243 |
| 123 | Dysdiadochokinesis (HP:0002075) | 2.09635040 |
| 124 | Abnormality of macular pigmentation (HP:0008002) | 2.07727184 |
| 125 | Polyphagia (HP:0002591) | 2.05807840 |
| 126 | Hypopigmentation of the fundus (HP:0007894) | 2.05462368 |
| 127 | Depression (HP:0000716) | 2.05270194 |
| 128 | Sleep apnea (HP:0010535) | 2.04090468 |
| 129 | Abnormal eating behavior (HP:0100738) | 2.01792623 |
| 130 | Neonatal short-limb short stature (HP:0008921) | 2.01652600 |
| 131 | Anxiety (HP:0000739) | 1.99321648 |
| 132 | Hammertoe (HP:0001765) | 1.97643081 |
| 133 | Focal dystonia (HP:0004373) | 1.97545377 |
| 134 | Spinal canal stenosis (HP:0003416) | 1.97267922 |
| 135 | Abnormality of the foot musculature (HP:0001436) | 1.96779972 |
| 136 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.96032372 |
| 137 | Onion bulb formation (HP:0003383) | 1.95043649 |
| 138 | Dry hair (HP:0011359) | 1.94429770 |
| 139 | Bronchomalacia (HP:0002780) | 1.93277489 |
| 140 | Diminished motivation (HP:0000745) | 1.92022087 |
| 141 | Adactyly (HP:0009776) | 1.90855260 |
| 142 | Cervical subluxation (HP:0003308) | 1.89665433 |
| 143 | Abnormality of the periventricular white matter (HP:0002518) | 1.89398833 |
| 144 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.89325837 |
| 145 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.89197931 |
| 146 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.89197931 |
| 147 | Abnormality of glycolipid metabolism (HP:0010969) | 1.89197931 |
| 148 | Hypoalphalipoproteinemia (HP:0003233) | 1.89112480 |
| 149 | Corneal erosion (HP:0200020) | 1.88686663 |
| 150 | Stereotypic behavior (HP:0000733) | 1.87378123 |
| 151 | Craniofacial dystonia (HP:0012179) | 1.86103669 |
| 152 | Polydipsia (HP:0001959) | 1.85444497 |
| 153 | Abnormal drinking behavior (HP:0030082) | 1.85444497 |
| 154 | Maternal diabetes (HP:0009800) | 1.84835045 |
| 155 | Cerebral hypomyelination (HP:0006808) | 1.84175264 |
| 156 | Thickened helices (HP:0000391) | 1.82668135 |
| 157 | Depressed nasal tip (HP:0000437) | 1.82410102 |
| 158 | Impaired vibratory sensation (HP:0002495) | 1.81600493 |
| 159 | Broad-based gait (HP:0002136) | 1.81201511 |
| 160 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.80800355 |
| 161 | Mucopolysacchariduria (HP:0008155) | 1.80800355 |
| 162 | Abnormal urine output (HP:0012590) | 1.79188229 |
| 163 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.77240163 |
| 164 | Arterial tortuosity (HP:0005116) | 1.76411127 |
| 165 | Atrioventricular block (HP:0001678) | 1.74922285 |
| 166 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.74816947 |
| 167 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.74816947 |
| 168 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.74816947 |
| 169 | Aplasia/hypoplasia of the femur (HP:0005613) | 1.73528381 |
| 170 | Hyperglycinuria (HP:0003108) | 1.72839809 |
| 171 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 1.72654932 |
| 172 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.70335105 |
| 173 | Homocystinuria (HP:0002156) | 1.69010517 |
| 174 | Abnormality of homocysteine metabolism (HP:0010919) | 1.69010517 |
| 175 | Aplasia/Hypoplasia of the clavicles (HP:0006710) | 1.68175343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MUSK | 6.89095092 |
| 2 | TNIK | 5.40998161 |
| 3 | EPHA4 | 3.73920707 |
| 4 | NTRK2 | 3.43376001 |
| 5 | PHKG2 | 2.65361900 |
| 6 | PHKG1 | 2.65361900 |
| 7 | NTRK3 | 2.54784583 |
| 8 | LMTK2 | 2.52290111 |
| 9 | MKNK2 | 2.50975220 |
| 10 | MAP2K7 | 1.81596603 |
| 11 | TRIB3 | 1.76035191 |
| 12 | GRK7 | 1.70671114 |
| 13 | CASK | 1.69770006 |
| 14 | MINK1 | 1.68382832 |
| 15 | MAPK12 | 1.67807357 |
| 16 | PRKD3 | 1.66841493 |
| 17 | NTRK1 | 1.62115087 |
| 18 | MARK1 | 1.60174827 |
| 19 | STK39 | 1.54231205 |
| 20 | GRK5 | 1.51812991 |
| 21 | TGFBR2 | 1.40438757 |
| 22 | GRK1 | 1.39929545 |
| 23 | MAP3K4 | 1.39789295 |
| 24 | MAP3K9 | 1.39663232 |
| 25 | PLK2 | 1.37329807 |
| 26 | MAPK13 | 1.31204318 |
| 27 | PRKCG | 1.29992952 |
| 28 | SGK2 | 1.20988608 |
| 29 | MOS | 1.20158095 |
| 30 | MAPK7 | 1.12043321 |
| 31 | SIK1 | 1.11368578 |
| 32 | MET | 1.10255139 |
| 33 | MAP3K13 | 1.09350529 |
| 34 | SGK3 | 1.08988401 |
| 35 | ADRBK1 | 1.04599839 |
| 36 | SGK494 | 1.02029923 |
| 37 | SGK223 | 1.02029923 |
| 38 | CDK5 | 1.00070520 |
| 39 | CAMKK1 | 0.99317824 |
| 40 | LATS2 | 0.98818698 |
| 41 | PNCK | 0.98141986 |
| 42 | PAK6 | 0.97448762 |
| 43 | ARAF | 0.94328504 |
| 44 | PINK1 | 0.93179925 |
| 45 | MAP2K4 | 0.91694267 |
| 46 | TNK2 | 0.91022691 |
| 47 | WNK1 | 0.90688413 |
| 48 | STK38 | 0.84783087 |
| 49 | PRKCE | 0.84607910 |
| 50 | CAMK2A | 0.83118597 |
| 51 | STK11 | 0.82515373 |
| 52 | DYRK1A | 0.79048266 |
| 53 | FGFR2 | 0.78796077 |
| 54 | BMPR2 | 0.76901445 |
| 55 | RIPK1 | 0.76704581 |
| 56 | MARK2 | 0.76093551 |
| 57 | RAF1 | 0.75839102 |
| 58 | CDK19 | 0.74148422 |
| 59 | CDK3 | 0.73739053 |
| 60 | MAPKAPK5 | 0.73188190 |
| 61 | MKNK1 | 0.72834744 |
| 62 | FGFR3 | 0.71667760 |
| 63 | NEK6 | 0.70290265 |
| 64 | CAMK2G | 0.68449521 |
| 65 | TYRO3 | 0.67388828 |
| 66 | RIPK4 | 0.65440018 |
| 67 | BRAF | 0.64304511 |
| 68 | CAMK4 | 0.63888039 |
| 69 | DAPK2 | 0.63737258 |
| 70 | MAP3K7 | 0.63502407 |
| 71 | INSRR | 0.62797327 |
| 72 | DAPK1 | 0.61924738 |
| 73 | FES | 0.60605210 |
| 74 | PRKCZ | 0.60268788 |
| 75 | IRAK3 | 0.60131079 |
| 76 | BMPR1B | 0.58288679 |
| 77 | SGK1 | 0.57344846 |
| 78 | PRPF4B | 0.55710997 |
| 79 | PRKG1 | 0.54236189 |
| 80 | RET | 0.52691434 |
| 81 | FGR | 0.51406624 |
| 82 | ALK | 0.51057921 |
| 83 | CDK15 | 0.50879299 |
| 84 | MAP3K1 | 0.50862750 |
| 85 | IGF1R | 0.50767878 |
| 86 | PRKD1 | 0.50538020 |
| 87 | PTK2B | 0.50477207 |
| 88 | CAMK1G | 0.50194997 |
| 89 | CAMK1 | 0.50106841 |
| 90 | SIK2 | 0.49444066 |
| 91 | PRKCA | 0.48767696 |
| 92 | RPS6KA3 | 0.48492900 |
| 93 | CDK18 | 0.47853175 |
| 94 | CDC42BPA | 0.47506196 |
| 95 | CAMK2B | 0.47164273 |
| 96 | MAP3K2 | 0.46287583 |
| 97 | PDK1 | 0.45662323 |
| 98 | ROCK1 | 0.45608119 |
| 99 | CSNK1G2 | 0.45461348 |
| 100 | ROCK2 | 0.44584154 |
| 101 | BRSK1 | 0.44461730 |
| 102 | CSNK1D | 0.44314977 |
| 103 | PRKACG | 0.44243525 |
| 104 | PRKCH | 0.42355463 |
| 105 | KSR1 | 0.41853299 |
| 106 | MAPK4 | 0.41266893 |
| 107 | PAK3 | 0.40955091 |
| 108 | PRKACB | 0.40734355 |
| 109 | DDR2 | 0.40197055 |
| 110 | CDK11A | 0.39986020 |
| 111 | JAK2 | 0.38841926 |
| 112 | PKN1 | 0.38657673 |
| 113 | PRKACA | 0.38076486 |
| 114 | CAMK2D | 0.37976149 |
| 115 | PRKCB | 0.37755680 |
| 116 | ERBB4 | 0.35491336 |
| 117 | UHMK1 | 0.35182235 |
| 118 | PBK | 0.34933948 |
| 119 | BMX | 0.34610405 |
| 120 | MAPK10 | 0.34401240 |
| 121 | CAMKK2 | 0.33881626 |
| 122 | OXSR1 | 0.33725942 |
| 123 | PRKAA2 | 0.33603994 |
| 124 | PDPK1 | 0.33264344 |
| 125 | FYN | 0.32475420 |
| 126 | FGFR1 | 0.32147342 |
| 127 | WNK4 | 0.32137174 |
| 128 | CDK14 | 0.31319088 |
| 129 | SRC | 0.30517052 |
| 130 | KSR2 | 0.29528637 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.96346832 |
| 2 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 4.43239162 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.36458793 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.95620775 |
| 5 | Phototransduction_Homo sapiens_hsa04744 | 2.31410183 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.18811879 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.09770305 |
| 8 | Salivary secretion_Homo sapiens_hsa04970 | 2.07748738 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.93294836 |
| 10 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.78618023 |
| 11 | Circadian entrainment_Homo sapiens_hsa04713 | 1.74967495 |
| 12 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.74081175 |
| 13 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.68432703 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.64857402 |
| 15 | Circadian rhythm_Homo sapiens_hsa04710 | 1.64775734 |
| 16 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.63620274 |
| 17 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.63569233 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.59858994 |
| 19 | Morphine addiction_Homo sapiens_hsa05032 | 1.58824431 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.58514435 |
| 21 | Olfactory transduction_Homo sapiens_hsa04740 | 1.54127431 |
| 22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.48547063 |
| 23 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.41098658 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.35351340 |
| 25 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.34213199 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.32669909 |
| 27 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.30397620 |
| 28 | Cocaine addiction_Homo sapiens_hsa05030 | 1.28851530 |
| 29 | Long-term potentiation_Homo sapiens_hsa04720 | 1.28417068 |
| 30 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.25156381 |
| 31 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.19245574 |
| 32 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.17962793 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.17919128 |
| 34 | Taste transduction_Homo sapiens_hsa04742 | 1.15733686 |
| 35 | Renin secretion_Homo sapiens_hsa04924 | 1.13135186 |
| 36 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.11985797 |
| 37 | Mineral absorption_Homo sapiens_hsa04978 | 1.09308083 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.09012789 |
| 39 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.08328134 |
| 40 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.01763494 |
| 41 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.01558744 |
| 42 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.00941374 |
| 43 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.00180118 |
| 44 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.96594020 |
| 45 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.96438622 |
| 46 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.95562816 |
| 47 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.93879675 |
| 48 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.92027559 |
| 49 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.87828786 |
| 50 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.87036304 |
| 51 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.86388867 |
| 52 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.86122571 |
| 53 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.84418588 |
| 54 | Gap junction_Homo sapiens_hsa04540 | 0.83390631 |
| 55 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.82844814 |
| 56 | Lysosome_Homo sapiens_hsa04142 | 0.79249148 |
| 57 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.77291285 |
| 58 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.76832010 |
| 59 | Long-term depression_Homo sapiens_hsa04730 | 0.76682028 |
| 60 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.73909749 |
| 61 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.70717305 |
| 62 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69783102 |
| 63 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.69533822 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.68537344 |
| 65 | Other glycan degradation_Homo sapiens_hsa00511 | 0.68297379 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68287830 |
| 67 | Melanogenesis_Homo sapiens_hsa04916 | 0.68242028 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67923325 |
| 69 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.67449097 |
| 70 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.67287891 |
| 71 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.66523924 |
| 72 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.66465058 |
| 73 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65104856 |
| 74 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64390637 |
| 75 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.64185391 |
| 76 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.63845234 |
| 77 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63353036 |
| 78 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.61160929 |
| 79 | Endocytosis_Homo sapiens_hsa04144 | 0.59714825 |
| 80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.59655300 |
| 81 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.59403440 |
| 82 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59149883 |
| 83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58904408 |
| 84 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.58771674 |
| 85 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.58623616 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58493645 |
| 87 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.58233881 |
| 88 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.57809480 |
| 89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.56652486 |
| 90 | Tight junction_Homo sapiens_hsa04530 | 0.54536961 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54056686 |
| 92 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.53784619 |
| 93 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.52915304 |
| 94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52670891 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50720384 |
| 96 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.49777202 |
| 97 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49704262 |
| 98 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.47876612 |
| 99 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.47369677 |
| 100 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47234280 |
| 101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.47016434 |
| 102 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.45793096 |
| 103 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42393323 |
| 104 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.41418231 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41066301 |
| 106 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.41001993 |
| 107 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.37002458 |
| 108 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36906469 |
| 109 | Endometrial cancer_Homo sapiens_hsa05213 | 0.36867022 |
| 110 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.36822625 |
| 111 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.36422450 |
| 112 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.35809994 |
| 113 | Glioma_Homo sapiens_hsa05214 | 0.35673411 |
| 114 | Prion diseases_Homo sapiens_hsa05020 | 0.35539997 |
| 115 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.35451204 |
| 116 | ABC transporters_Homo sapiens_hsa02010 | 0.34904211 |
| 117 | Axon guidance_Homo sapiens_hsa04360 | 0.34155189 |
| 118 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33289559 |
| 119 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33187292 |
| 120 | Peroxisome_Homo sapiens_hsa04146 | 0.32314580 |
| 121 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.31828320 |
| 122 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.30776700 |
| 123 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.29282391 |
| 124 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.27609762 |
| 125 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.26634883 |
| 126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.21643087 |

